Survival analysis showed that patients with low ATP7B expression had significantly shorter overall survival in both GBM and LGG cohorts, indicating that the loss or downregulation of ATP7B is closely associated with poor prognosis (Figure 8F–H). Here, ATP7B is linked to glioblastoma.